Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience. (Q44754640)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 May 2013

Language	Label	Description	Also known as
English	Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.	scientific article published on 17 May 2013

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

oligodendroglioma

1 reference

based on heuristic

inferred from title

anaplastic oligodendroglioma

1 reference

based on heuristic

inferred from title

adult oligodendroglioma

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Jean-Sébastien Frénel

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

C Leux

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

D Loussouarn

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A-G Le Loupp

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

F Leclair

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Aumont

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A Mervoyer

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Martin

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Campone

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

17 May 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

114

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

85-91

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

https://scigraph.springernature.com/pub.10.1007/s11060-013-1152-0

0 references

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

IDH1 and IDH2 mutations in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Monoclonal antibody specific for IDH1 R132H mutation

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

IDH1 and IDH2 mutations in gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice – a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Loss of chromosome 1p/19q in oligodendroglial tumors: refinement of chromosomal critical regions and evaluation of internexin immunostaining as a surrogate marker.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1152-0

21 January 2018

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23681562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-013-1152-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23681562%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44754640&oldid=1628128407"